What happens to people’s health when air pollution is reduced? - The Guardian

Boston, MA—Infants born to mothers who ate a healthy, Mediterranean-style diet during pregnancy were at lower risk for colic and eczema, according to a new study by researchers at Harvard T. H. Chan School of Public Health, Boston Children’s Hospital, and Harvard Pilgrim Health Care Institute. The researchers also found that regularly consuming seafood during pregnancy helped lower an infant’s risk for these conditions. “Our own prior studies have shown that babies who had colic have higher rates of atopic conditions in later life, including asthma, seasonal rhinitis and food allergies,” said corresponding author Jenifer Lightdale, associate chief of the Division of Gastroenterology, Hepatology and Nutrition at Boston Children’s Hospital and professor of pediatrics at Harvard Medical School. “Our new study is the first to ask how prenatal diet may influence colic, and in particular the combination of colic and eczema, as babies who have both conditions in infancy may be at highest risk for various manifestations of allergies when they are older.”

AtlanticNova ScotiaNew BrunswickPrince Edward Island Newfoundland and LabradorCalgaryLethbridgeKitchenerGuelphNorthern OntarioSudburyNorth BaySault Ste. MarieTimminsOttawaKingstonBrockvillePembrokeReginaYorktonSaskatoonPrince AlbertTorontoWatchWeatherPeelHamiltonDurhamYorkHaltonNiagaraQueen's ParkToronto City HallIn PicturesVancouverVancouver IslandCanadaLocal SpotlightRoyal FamilyPoliticsNanosPower PlayQuestion PeriodFederal Election 2025WorldMideast ConflictRussia-Ukraine WarWatchLatestCaptured on CameraPoliticsLifestyleConsumerHealthExplainedEntertainmentTechnologyDeception DecodedAutosEnvironmentBusinessInflationReal EstateAutos

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.